Copyright
©2014 Baishideng Publishing Group Co.
World J Nephrol. Feb 6, 2014; 3(1): 6-15
Published online Feb 6, 2014. doi: 10.5527/wjn.v3.i1.6
Published online Feb 6, 2014. doi: 10.5527/wjn.v3.i1.6
Table 1 Clinical characteristics at renal biopsy n (%)
| Total | n = 45 |
| Age (yr) (range) | 58.3 ± 13.3 (28-84) |
| Sex (men) | 32 (71.1) |
| Diabetes type 2 | 38 (84.4) |
| Diabetes duration (yr) (range) | 9.6 ± 7.8 (0-35) |
| BMI (kg/m2) (range) | 29.3 ± 5.3 (27.8-47.8) |
| Obesity BMI > 30 kg/m2 | 18 (40.9) |
| Hypertension (yes) | 42 (93.3) |
| Smoker, active or past (yes) | 34 (75.6) |
| Dyslipidemic (yes) | 33 (73.3) |
| Ischemic heart disease (yes) | 7 (15.6) |
| CVA (yes) | 6 (13.3) |
| Peripheral arterial disease (yes) | 8 (17.8) |
| Any CVD | 16 (35.6) |
| Hematuria (yes) | 18 (41.9) |
| Serum albumin (g/dL) (range) | 3.4 ± 0.7 (2-5) |
| HbA1c% (range) | 6.5 ± 1.4 (4.1-9.3) |
| Total cholesterol (mg/dL) | 177.9 ± 58.7 |
| Previous nephrology care (yr) (range) | 1.21 ± 2.4 (0-12) |
| RAASI treatment | 40 (88.9) |
| Statin treatment | 33 (73.3) |
| Antiplatelet drug treatment | 21 (46.7) |
- Citation: López-Revuelta K, Galdo PP, Stanescu R, Parejo L, Guerrero C, Pérez-Fernández E. Silent diabetic nephropathy. World J Nephrol 2014; 3(1): 6-15
- URL: https://www.wjgnet.com/2220-6124/full/v3/i1/6.htm
- DOI: https://dx.doi.org/10.5527/wjn.v3.i1.6